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After inflammatory stimuli, the rates of hepatic synthesis of several plasma
proteins, the acute-phase proteins (APP), increase dramatically while some others,
most notably albumin, decrease substantially (1). Amongthese APP are a number
of glycoproteins that manifest microheterogeneity as a result of structural vari-
ations of their glycan chains. Increased plasma levels of APP are often accom-
panied by changes in the patterns of glycosylation of some of these proteins (2-
6), readily detected as changes in relative affinity to lectins such as Con A . While
monokines, products of activated mononuclear phagocytes, are known to play a
major role in regulation of APP gene expression, leading to increased or
decreased synthesis and secretion of plasma proteins (7-10), the mechanisms
governing the alterations in glycosylation of APP are not known. It has not been
firmly established whether these changes in glycosylation reflect differences
occurring within hepatocytes or whether they reflect differential clearance of
various glycosylated forms of APP from the circulation. If the former possibility
is the case, it is unclear whether a common mediator induces both changes of
APP synthesis and changes in their patterns of glycosylation, or whether separate
mechanismsare responsible for these alterations. The lack of correlation between
changes in concentration and pattern of glycosylation of a, acid glycoprotein in
certain clinical states suggests that different mechanisms mediate these changes
(5). To study the mechanisms governing both glycosylation and synthesis of APP
in a single system, we used the human hepatoma cell line Hep 3B as a model.
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Preparation of Conditioned Medium (CM).
￿
Human monocytes were isolated from hepa-
rinized peripheral blood by Ficoll-Hypaque gradient centrifugation followed by attach-
ment to plastic culture dishes (100 mm) for 1 .5 h in RPMI 1640 (Mediatech-Fisher
Scientific Co., Springfield, NJ) with 20% FCS (Gibco Laboratories, Grand Island, NY).
Adherent cells (1 .5 x 106/dish) were washed and incubated for 24 h in 5 ml of serum-
free RPMI 1640 with dexamethasone (1 AM/ml), insulin (0.02 U/ml), and LPS (20 pg/ml).
As expected, after incubation in the presence of dexamethasone (I1), CM tested by the
thymocyte proliferation assay (12) did not show IL-1 activity.
Induction of APP in the Hep 3B Cell Line.
￿
After subculture, cells were maintained in
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RPMI 1640 with 10% FCS, dexamethasone (1 AM/ml), and insulin (0.02 U/ml) for 5 d
and then for 24 h in serum-free RPMI 1640 supplemented with dexamethasone and
insulin. At this point (time 0), Hep 3B cells were exposed to a number of inducers of
acute phase protein changes: (a) CM prepared from LPS-activated human monocytes, (b)
recombinant generated human IL-Iß, a generous gift of Dr. C. A. Dinarello (Tufts
University Medical School, Boston, MA), (c) recombinant generated human tumor necrosis
factor (TNF), kindly provided by Dr. B. A. Beutler (University of Texas, Dallas, TX), (d)
medium from the keratocarcinoma cell line, COLD-16, which contains hepatocyte-
stimulating factor (HSF), and (e-g) COLO-16-derived purified HSF I, II, and III (8), a
generous gift of Dr. H. Baumann (Roswell Park Medical Institute, Buffalo, NY). In other
experiments, cells were exposed to tunicamycin (2 jug/ml). Cells were then incubated for
an additional 24, 48, 72, or 96 h with replacement of medium every 24 h. Analyses were
carried out in media collected over the final 24 h. Each experiment was run in triplicate.
Quantitation of APP Accumulated in Culture Media.
￿
Concentrations of albumin, a,
proteinase inhibitor (aPI) and ceruloplasmin (Cp) secreted by Hep 3B cells into culture
media were determined by quantitative electroimmunoassay (13) with monospecific anti-
bodies, using a human serum calibrator kit (Atlantic Antibodies, Scarborough, ME) as a
standard. Results were expressed as percentage of increase or decrease over control
experiments.
Determination of aPI and Cp Microheterogeneity.
￿
Patterns of glycosylation were studied
by means of agarose affinity electrophoresis (AFF-EP) with free Con A as a ligand (14).
Briefly, in the first dimension of AFF-EP, 40,uM Con A (Sigma Chemical Co., St. Louis,
MO) was incorporated into agarose, and culture medium was added to the application
well. Electrophoresis was run for 1 h at 10 V/cm and the gel was transferred onto the
second dimension plate. Two gels were cast, one containing anti-aPI or anti-Cp antibodies,
and the second an intermediate gel containing 0.3 M a-methyl-n-mannoside (to dissolve
Con A-glycoprotein complexes). Electrophoresis in the second dimension was run for 18
h at 2 V/cm. The gel was then washed, dried, and stained with Coomassie Brilliant Blue
R250 (Sigma Chemical Co.). The area under the precipitate curves was determined by
planimetry and the relative amounts of the different microheterogeneous forms were
expressed as percentages of the total . A reactivity coefficient (RC) for each sample was
calculated according to the formula: sum of Con A reactive variants/Con A nonreactive
variant.
All statistical analyses were carried out by the Mann-Whitney test.
Results
Exposure of Hep 3B cells to varying amounts of CM and to supernatant
obtained from the COLO 16 line resulted in dose-dependent reduction in
accumulation of albumin and increase of accumulation of aPI and Cp (Table I).
Incubation with IL-1, TNF, and HSF I caused reduction ofalbumin and increase
of Cp accumulation, but had no effect on aPI . HSF II and HSF III did not
significantly affect accumulation of any of the proteins studied. The changes
described were most pronounced after 48 h of incubation (Table II).
AFF-EP revealed three microheterogeneous variants of aPI : one nonreactive
and two reactive with Con A, and four variants of Cp: two nonreactive and two
reactive with the lectin (Fig. 1). Incubation of Hep 3B cells with CM and COLO
16 caused increased accumulation of forms of aPI and Cp reactive with Con A
compared to controls (p < 0.001) (Fig. 1 and Table I). These changes were dose
(Fig. 2) and time (Table II) dependent, reaching a maximum at 72 h of culture.
The effect was reversed within 24 h of removal of CM from the cell culture
medium. None of the other purified or recombinant monokines affected reactiv-
ity of aPI or Cp with Con A. Addition of tunicamycin, known to block theTABLE I
Accumulation ofAlb, aPl, and Cp and Glycosylation Patterns ofaPland Cp Secreted into
CultureMedium by Hep 3B Cells Exposed to Putative Inducersfor 48 h
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* Mean ± SD.
* Differences statistically significant when compared with control (P < 0.001).
TABLE II
Time-dependent Changes in Accumulation over a 24-h Period and
Reactivity with Con A ofaPlSecreted by Hep 3B Exposed to 10% CM
for Various Time Periods
* aP1 accumulation at each time point is expressed as percentage increase over the
corresponding control.
* Mean ± SD.
Reactivity coefficient of aPI in control cultures, in the absence ofadded inducers,
did not change significantly in any time period.
synthesis of N-glycosidically linked oligosaccharides, completely inhibited reac-
tivity ofboth APP with the lectin (results not shown).
Discussion
Several mechanisms could be responsible for the effect of CM on patterns of
glycosylation ofaPI and Cp. Human aPI and Cp both consistofone polypeptide
chain containing three oligosaccharides attached to three separate asparagine
residues by N-glycosyl linkages. Both of these APP exhibit multiple microheter-
ogeneous forms in serum, differing in the composition oftheir bi- and trianten-
nary heteroglycan structures (15-17). Con A binds unsubstituted hydroxyl
groups at carbons 3, 4, or 6 of a-linked 2-0-substituted mannose residues, and
at least two interacting molecules are required for this binding (18). Only
biantennary structures of aPI and Cp react with the lectin, while triantennary
structures do not. Thus, the alterations in glycosylation patterns observed in the
present studies may reflect a relative increase ofbi- over triantennary structures
attached tothe polypeptide chain. It is possible thatvarious glycosylating enzymes
could be activated or depressed by constituents of CM (19). There could, for
Inducer n
Alb
Accumulation
apl Cp
Glycosylation
PI
pattern (RC)
Cp
Control 12 100 100 100 1.67 ± 0.1 * 0.34 ± 0.01
CM (10%) 12 29 ± 5* 359 ± 18* 1642 ± 120* 3.55 ± 0.12* 0.85 ± 0.021:
IL-1 (1 .25 ng/ml) 8 36 ± 41: 105 ± 10 446 ± 52$ 1 .7 ± 0.11 0.33 ± 0.02
TNF (250 ng/ml) 6 36 ± 31: 103 ± 8 348 ± 32* 1.65 ± 0.13 0.32 ± 0.01
COLO-16 (10%) 6 38 ± 2* 154 ± P 608 ± 651: 3.0 ± 0.1* 0.72 ± 0.03*
HSF 1 (10%) 2 54 ± 1* 98 ± 2 385 ± 26* 1.68 ± 0.11 0.34 ± 0.01
HSF11(10%) 2 90±3 99±1 105±8 1.67±0.12 0.34±0.01
HSF111(10%) 2 101±2 101±2 103±10 1.66±0.11 0.33±0.02
Period of incubation Accumulation Glycosylation changes (RC)
h
Control 100* 1.67 ± 0.11
24 171 ± 26* 2.95 ± 0.6
48 359 ± 18 3.55 ± 0.21
72 252 ± 13 4.77 ± 0.19
96 227 ± 22 3.92 ± 0.13s
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FIGURE 1 .
￿
Affinity electrophoresis (AFF-EP) of aPI (top) and Cp (bottom) synthesized and
secreted by Hep 3B cells . (a) Supernatant from Hep 3B cells maintained in culture medium
alone for 48 h subjected to electrophoresis in the absence ofCon A in the first dimension . (b)
The same sample as in a, except that electrophoresis was carried out in the presence of Con
A; (top) variant 0, nonreactive with ConA (migrating to thesame distance as aPI in a) ; variant
1, weakly reactive with ConA; and variant 2, strongly reactive with ConA. (Bottom) Variants
A and B0, nonreactive with ConA; variant B1, weakly reactive with ConA; and variant B2,
strongly_reactive with Con A. (c) Medium from Hep 3B cells incubated with 10%CM for48
h .
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FIGURE 2 . Dose-dependent changes of relative amounts of
threeaPI variants secreted by Hep3B exposed toCM for 48 h .
Variant 0, nonreactive with Con A; variant 1, weakly reactive
with ConA; variant 2, strongly reactive withConA.
example, be a decrease in synthesis or activity of the ,B-N-acetylglucosaminyl
transferase that converts the biantennary to triantennary oligosaccharides . A
second possibility is that other glycosylating enzymesthat use thesame substrates
are activated . Finally, it is possible that different kinetics of intracellular transport
or different routing may occur in hepatocytes during the acute phase response,
with resulting alteration in glycosylation . It has been suggested (3) that increased
rate of protein synthesis and lack of parallel activation of certain transferases
may result in increase of attached biantennary structures . This possibility seems
to be least likely, as increased synthesis of Cp induced by IL-1, TNF, and HSF IMACKIEWICZ ET AL .
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in these studies was not accompanied bychanges in its glycosylation . In addition,
we observed a time-dependent, diminishing response to induction by CM while
the effect on glycosylation pattern ofaPI was not affected by time (Table II) .
These studies demonstrate that changes of APP glycosylation seen in human
sera during various inflammatory states canbe explainedby alterations occurring
within hepatocytes, and that these changes are regulated by one or more
monokines. Different mechanisms appear to regulate synthesis and glycosylation
of APP, since changes in rates of synthesis ofCp caused by IL-1, TNF, and HSF
I were not accompanied by alterations in glycosylation of this protein and the
time required for maximal induction and maximal reactivity with ConA of aPI
varied substantially .
Summary
The acute-phase response to inflammatory stimuli, characterized by increased
synthesis of acute-phase proteins (APP), is often accompanied by changes in the
glycosylation patterns of some of these proteins . While expression of APP genes
in hepatocytes is regulated by monokines, mechanisms governing changes in
glycosylation are not known . Exposure ofhuman hepatoma cell line Hep 3B to
conditionedmedium from LPS-activated human monocytes and to medium from
the keratocarcinoma cell line COLO-16 led to increased synthesis of a, protein-
ase-inhibitor and ceruloplasmin and to alterations of their glycosylation patterns
similar to those seen in human serum in various inflammatory states . IL-1, tumor
necrosis factor, and hepatocyte stimulating factor I increased synthesis of ceru-
loplasmin without alterations in the pattern of its glycosylation . These findings
demonstrate that altered glycosylation seen in plasma in some inflammatory
states can be explained by the effects of monokines on glycosylation in hepato-
cytes and that gene expression and glycosylation ofsome APP during the acute-
phase response may be regulated by different mechanisms .
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